C6orf167 inhibitors pertain to a class of chemical compounds designed to interact with the protein encoded by the human gene C6orf167, also known as MICAL3 (molecule interacting with CasL protein 3). The name C6orf167 arises from its initial characterization as an open reading frame (ORF) on chromosome 6. The proteins in the MICAL family are known to be multi-domain flavoenzymes, which means they have the capacity to catalyze oxidation-reduction (redox) reactions using flavin adenine dinucleotide (FAD) as a cofactor. The precise biological function of C6orf167 is complex and multifaceted, involving the regulation of cytoskeletal dynamics. This includes its influence on actin filament disassembly and interactions with other proteins that are crucial for the maintenance of various cellular functions.
Inhibitors targeting C6orf167 are chemical agents that have been developed to specifically bind to this protein and modulate its activity. The design of such compounds typically stems from an understanding of the enzyme's structure and the key active sites that are essential for its enzymatic function. By binding to the MICAL3 protein, these inhibitors can affect the protein's ability to interact with its substrates or with other proteins within the cell. The development of inhibitors often involves the use of high-throughput screening techniques to identify potential molecules that demonstrate a high affinity for the target protein.
SEE ALSO...
Items 11 to 18 of 18 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Amsacrine hydrochloride | 54301-15-4 | sc-214540 | 10 mg | $232.00 | ||
Amsacrine affects topoisomerase II. By altering DNA dynamics, there could be an indirect effect on C6orf167 functionality. | ||||||
Daunorubicin hydrochloride | 23541-50-6 | sc-200921 sc-200921A sc-200921B sc-200921C | 10 mg 50 mg 250 mg 1 g | $103.00 $429.00 $821.00 $1538.00 | 4 | |
Daunorubicin, like doxorubicin, intercalates DNA, which could potentially influence processes in which C6orf167 is involved. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is known to modify DNA methylation patterns. Altered methylation might affect C6orf167 gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis. This could decrease C6orf167 expression by preventing its mRNA synthesis. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine incorporates into DNA and affects methylation. Changes in methylation might reduce C6orf167 gene expression. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $57.00 $200.00 | 15 | |
Fludarabine is a nucleoside analog that can interfere with DNA replication. This may lead to a decrease in C6orf167 expression. | ||||||
2-Chloro-2′-deoxyadenosine | 4291-63-8 | sc-202399 | 10 mg | $144.00 | 1 | |
Cladribine is another nucleoside analog. Its incorporation might interfere with DNA replication and C6orf167 expression. | ||||||
Teniposide | 29767-20-2 | sc-204910 sc-204910A | 25 mg 100 mg | $72.00 $230.00 | 6 | |
Teniposide inhibits topoisomerase II. By disrupting DNA dynamics, there might be an indirect effect on C6orf167 expression. |